News

AddToAny

Google+ Facebook Twitter Twitter

New diagnoses have plummeted in the pandemic

New diagnoses of common chronic conditions have dramatically declined during the COVID-19 pandemic, according to a new study.

Researchers in Spain analysed annual incidence rates of the main cardiovascular risk factors, chronic diseases, and some cancers in 2020, compared with data from 2017–2019.

They found a reduction in newly reported diagnoses ranging from a 36% decline for high cholesterol diagnoses, to a 50% decline in the diagnosis of pulmonary diseases, such as chronic bronchitis.

Additionally, the rate of diagnosis of anxiety disorders increased by 16%, while the diagnoses of alcohol use disorder decreased by 46%.

The authors note that the decline is not reflective of improved health outcomes, but suggests that people are not receiving appropriate and timely health screenings that would diagnose these conditions early, when there is a greater chance of effective treatment and good health outcomes.

They write that returning to the level of detection and control of chronic diseases before the pandemic will require a substantial increase in primary care physicians and nurses; a return to face-to-face visits; a reorganisation of telehealth; and the promotion of proactive care in patients who have the greatest comorbidities.

bit.ly/3o3s3k0

Image Credit | Shutterstock

Related Articles

soft tissue sarcoma CREDIT -shutterstock - 2302813459

Sarcoma relapse risk reduced by 43%

A global team of researchers has announced clinical trial results that point to a new immunotherapy treatment option for two of the most common types of soft tissue sarcoma in adults.

nephrotic syndrome you yes CREDIT - shutterstock -639997780

Under the microscope: nephrotic syndrome

This month: Nephrotic syndrome

eProtein Discovery side-CREDIT_Supplied

Tech round up: June 2024

Best new tech this month

Natural-killer cells attacking a cancer cel - CREDIT - Science-Photolibrary-f0339843

Predictive model for tumour-killing cells

Scientists have developed a powerful predictive model for identifying the most potent cancer-killing immune cells for use in cancer immunotherapies.

Top